Loading...
Header Logo
Keywords
Last Name
Institution

Dr Gregory Matlashewski

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zhang WW, Ghosh AK, Mohamath R, Whittle J, Picone A, Lypaczewski P, Ndao M, Howard RF, Das P, Reed SG, Matlashewski G. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients. BMC Infect Dis. 2018 Oct 03; 18(1):500. PMID: 30285653.
      View in: PubMed
    2. Zhang WW, Matlashewski G. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani. mBio. 2015 Jul 21; 6(4):e00861. PMID: 26199327.
      View in: PubMed
    3. Engwerda CR, Matlashewski G. Development of Leishmania vaccines in the era of visceral leishmaniasis elimination. Trans R Soc Trop Med Hyg. 2015 Jul; 109(7):423-4. PMID: 26048873.
      View in: PubMed
    4. McCall LI, Zhang WW, Dejgaard K, Atayde VD, Mazur A, Ranasinghe S, Liu J, Olivier M, Nilsson T, Matlashewski G. Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis. J Proteome Res. 2015 Feb 06; 14(2):1033-59. PMID: 25536015.
      View in: PubMed
    5. Zhang WW, Matlashewski G. Screening Leishmania donovani complex-specific genes required for visceral disease. Methods Mol Biol. 2015; 1201:339-61. PMID: 25388124.
      View in: PubMed
    6. Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P. Research priorities for elimination of visceral leishmaniasis. Lancet Glob Health. 2014 Dec; 2(12):e683-4. PMID: 25433617.
      View in: PubMed
    7. Das S, Matlashewski G, Bhunia GS, Kesari S, Das P. Asymptomatic Leishmania infections in northern India: a threat for the elimination programme? Trans R Soc Trop Med Hyg. 2014 Nov; 108(11):679-84. PMID: 25205664.
      View in: PubMed
    8. Khatun J, Huda MM, Hossain MS, Presber W, Ghosh D, Kroeger A, Matlashewski G, Mondal D. Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh. PLoS One. 2014; 9(8):e103678. PMID: 25090412.
      View in: PubMed
    9. Zhang WW, Ramasamy G, McCall LI, Haydock A, Ranasinghe S, Abeygunasekara P, Sirimanna G, Wickremasinghe R, Myler P, Matlashewski G. Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain. PLoS Pathog. 2014 Jul; 10(7):e1004244. PMID: 24992200.
      View in: PubMed
    10. Das VN, Pandey RN, Pandey K, Singh V, Kumar V, Matlashewski G, Das P. Impact of ASHA training on active case detection of visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis. 2014 May; 8(5):e2774. PMID: 24853122.
      View in: PubMed
    11. Fernandes AP, Canavaci AM, McCall LI, Matlashewski G. A2 and other visceralizing proteins of Leishmania: role in pathogenesis and application for vaccine development. Subcell Biochem. 2014; 74:77-101. PMID: 24264241.
      View in: PubMed
    12. Mondal D, Alvar J, Hasnain MG, Hossain MS, Ghosh D, Huda MM, Nabi SG, Sundar S, Matlashewski G, Arana B. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study. Lancet Glob Health. 2014 Jan; 2(1):e51-7. PMID: 25104636.
      View in: PubMed
    13. Ranasinghe S, Wickremasinghe R, Munasinghe A, Hulangamuwa S, Sivanantharajah S, Seneviratne K, Bandara S, Athauda I, Navaratne C, Silva O, Wackwella H, Matlashewski G, Wickremasinghe R. Cross-sectional study to assess risk factors for leishmaniasis in an endemic region in Sri Lanka. Am J Trop Med Hyg. 2013 Oct; 89(4):742-9. PMID: 23918217.
      View in: PubMed
    14. Mondal D, Huda MM, Karmoker MK, Ghosh D, Matlashewski G, Nabi SG, Kroeger A. Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh. Emerg Infect Dis. 2013 Jul; 19(7):1131-4. PMID: 23764246.
      View in: PubMed
    15. Matlashewski G, Das VN, Pandey K, Singh D, Das S, Ghosh AK, Pandey RN, Das P. Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum. PLoS Negl Trop Dis. 2013; 7(5):e2233. PMID: 23717700.
      View in: PubMed
    16. Küster T, Hermann C, Hemphill A, Gottstein B, Spiliotis M. Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice. PLoS Negl Trop Dis. 2013; 7(5):e2235. PMID: 23717701.
      View in: PubMed
    17. McCall LI, Zhang WW, Matlashewski G. Determinants for the development of visceral leishmaniasis disease. PLoS Pathog. 2013 Jan; 9(1):e1003053. PMID: 23300451.
      View in: PubMed
    18. Tsukayama P, Núñez JH, De Los Santos M, Soberón V, Lucas CM, Matlashewski G, Llanos-Cuentas A, Ore M, Baldeviano GC, Edgel KA, Lescano AG, Graf PC, Bacon DJ. A FRET-based real-time PCR assay to identify the main causal agents of New World tegumentary leishmaniasis. PLoS Negl Trop Dis. 2013; 7(1):e1956. PMID: 23301111.
      View in: PubMed
    19. McCall LI, Zhang WW, Ranasinghe S, Matlashewski G. Leishmanization revisited: immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis. Vaccine. 2013 Feb 27; 31(10):1420-5. PMID: 23219435.
      View in: PubMed
    20. Zhang WW, McCall LI, Matlashewski G. Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani. Eukaryot Cell. 2013 Jan; 12(1):70-7. PMID: 23125352.
      View in: PubMed
    21. Ranasinghe S, Zhang WW, Wickremasinghe R, Abeygunasekera P, Chandrasekharan V, Athauda S, Mendis S, Hulangamuwa S, Matlashewski G, Pratlong F. Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka. Pathog Glob Health. 2012 Nov; 106(7):421-4. PMID: 23265615.
      View in: PubMed
    22. Zhang WW, Matlashewski G. Deletion of an ATP-binding cassette protein subfamily C transporter in Leishmania donovani results in increased virulence. Mol Biochem Parasitol. 2012 Oct; 185(2):165-9. PMID: 22841683.
      View in: PubMed
    23. Raman VS, Duthie MS, Fox CB, Matlashewski G, Reed SG. Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol. 2012; 3:144. PMID: 22701453.
      View in: PubMed
    24. McCall LI, Matlashewski G. Involvement of the Leishmania donovani virulence factor A2 in protection against heat and oxidative stress. Exp Parasitol. 2012 Oct; 132(2):109-15. PMID: 22691540.
      View in: PubMed
    25. Zhang WW, Chan KF, Song Z, Matlashewski G. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs. Exp Parasitol. 2011 Dec; 129(4):337-45. PMID: 21978449.
      View in: PubMed
    26. Gosline SJ, Nascimento M, McCall LI, Zilberstein D, Thomas DY, Matlashewski G, Hallett M. Intracellular eukaryotic parasites have a distinct unfolded protein response. PLoS One. 2011 Apr 29; 6(4):e19118. PMID: 21559456.
      View in: PubMed
    27. Yam KK, Hugentobler F, Pouliot P, Stern AM, Lalande JD, Matlashewski G, Olivier M, Cousineau B. Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice. J Med Microbiol. 2011 Sep; 60(Pt 9):1248-1260. PMID: 21527547.
      View in: PubMed
    28. Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis. 2011 Apr; 11(4):322-5. PMID: 21453873.
      View in: PubMed
    29. Thomas M, Kranjec C, Nagasaka K, Matlashewski G, Banks L. Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J. 2011 Jan 19; 8:25. PMID: 21247458.
      View in: PubMed
    30. Zhang WW, Matlashewski G. Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol. 2010 Jul; 77(2):505-17. PMID: 20545850.
      View in: PubMed
    31. McCall LI, Matlashewski G. Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol Microbiol. 2010 Jul; 77(2):518-30. PMID: 20497497.
      View in: PubMed
    32. Miranda-Verastegui C, Tulliano G, Gyorkos TW, Calderon W, Rahme E, Ward B, Cruz M, Llanos-Cuentas A, Matlashewski G. First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS Negl Trop Dis. 2009 Jul 28; 3(7):e491. PMID: 19636365.
      View in: PubMed
    33. Zhang WW, Peacock CS, Matlashewski G. A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania. PLoS Negl Trop Dis. 2008 Jun 11; 2(6):e248. PMID: 18545684.
      View in: PubMed
    34. Ainsworth J, Thomas M, Banks L, Coutlee F, Matlashewski G. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses. Virol J. 2008 Jun 02; 5:67. PMID: 18518978.
      View in: PubMed
    35. Zhang WW, Matlashewski G. Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice. Infect Immun. 2008 Aug; 76(8):3777-83. PMID: 18474642.
      View in: PubMed
    36. Gregory DJ, Sladek R, Olivier M, Matlashewski G. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun. 2008 Mar; 76(3):1186-92. PMID: 18086813.
      View in: PubMed
    37. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Matlashewski G, Roger M, Ferenczy AS, Franco EL, Coutlée F. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer. 2007 Dec 15; 121(12):2674-81. PMID: 17708553.
      View in: PubMed
    38. Arevalo I, Tulliano G, Quispe A, Spaeth G, Matlashewski G, Llanos-Cuentas A, Pollack H. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clin Infect Dis. 2007 Jun 15; 44(12):1549-54. PMID: 17516397.
      View in: PubMed
    39. Nascimento M, Zhang WW, Ghosh A, Houston DR, Berghuis AM, Olivier M, Matlashewski G. Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence. J Biol Chem. 2006 Nov 24; 281(47):36257-68. PMID: 17005559.
      View in: PubMed
    40. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlée F. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis. 2006 Oct 01; 194(7):886-94. PMID: 16960775.
      View in: PubMed
    41. Zhang WW, Miranda-Verastegui C, Arevalo J, Ndao M, Ward B, Llanos-Cuentas A, Matlashewski G. Development of a genetic assay to distinguish between Leishmania viannia species on the basis of isoenzyme differences. Clin Infect Dis. 2006 Mar 15; 42(6):801-9. PMID: 16477557.
      View in: PubMed
    42. Stewart D, Ghosh A, Matlashewski G. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J Virol. 2005 Jul; 79(14):8773-83. PMID: 15994771.
      View in: PubMed
    43. Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev. 2005; 29(4):307-16. PMID: 16122882.
      View in: PubMed
    44. Zhang WW, Matlashewski G. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major. Mol Microbiol. 2004 Nov; 54(4):1051-62. PMID: 15522086.
      View in: PubMed
    45. Ghosh A, Stewart D, Matlashewski G. Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol. 2004 Sep; 24(18):7987-97. PMID: 15340061.
      View in: PubMed
    46. Stewart D, Kazemi S, Li S, Massimi P, Banks L, Koromilas AE, Matlashewski G. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J Gen Virol. 2004 Jun; 85(Pt 6):1419-1426. PMID: 15166424.
      View in: PubMed
    47. Kazemi S, Papadopoulou S, Li S, Su Q, Wang S, Yoshimura A, Matlashewski G, Dever TE, Koromilas AE. Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol Cell Biol. 2004 Apr; 24(8):3415-29. PMID: 15060162.
      View in: PubMed
    48. Nascimento M, Abourjeily N, Ghosh A, Zhang WW, Matlashewski G. Heterologous expression of a mammalian protein tyrosine phosphatase gene in Leishmania: effect on differentiation. Mol Microbiol. 2003 Dec; 50(5):1517-26. PMID: 14651635.
      View in: PubMed
    49. Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun. 2003 Jul; 71(7):3988-94. PMID: 12819086.
      View in: PubMed
    50. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, Clos J, Sacks DL, Matlashewski G. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem. 2003 Sep 12; 278(37):35508-15. PMID: 12829719.
      View in: PubMed
    51. Carvalho FA, Charest H, Tavares CA, Matlashewski G, Valente EP, Rabello A, Gazzinelli RT, Fernandes AP. Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn Microbiol Infect Dis. 2002 Aug; 43(4):289-95. PMID: 12151189.
      View in: PubMed
    52. Arevalo I, Ward B, Matlashewski G. Detection of iNOS gene expression in cutaneous leishmaniasis biopsy tissue. Mol Biochem Parasitol. 2002 Apr 30; 121(1):145-7. PMID: 11985871.
      View in: PubMed
    53. Li S, Labrecque S, Gauzzi MC, Cuddihy AR, Wong AH, Pellegrini S, Matlashewski GJ, Koromilas AE. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene. 1999 Oct 14; 18(42):5727-37. PMID: 10523853.
      View in: PubMed
    54. Labrecque S, Matlashewski GJ. Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53. Oncogene. 1995 Jul 20; 11(2):387-92. PMID: 7624152.
      View in: PubMed
    55. Peacock JW, Matlashewski GJ, Benchimol S. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts. Oncogene. 1990 Dec; 5(12):1769-74. PMID: 2178238.
      View in: PubMed
    56. Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A. 1990 Aug; 87(15):5863-7. PMID: 2143022.
      View in: PubMed
    57. Denis M, Chadee K, Matlashewski GJ. Macrophage killing of human papillomavirus type 16-transformed cells. Virology. 1989 May; 170(1):342-5. PMID: 2541555.
      View in: PubMed
    58. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol. 1987 Feb; 7(2):961-3. PMID: 3547088.
      View in: PubMed
    59. Fabijanski S, Matlashewski GJ, Altosaar I. Characterization of developing oat seed mRNA: evidence for many globulin mRNAs. Plant Mol Biol. 1985 Jul; 4(4):205-10. PMID: 24310836.
      View in: PubMed
    60. Garson K, Matlashewski GJ, Adeli K, Robert LS, Altosaar I. Isolation of intact polysomes from mechanically dehulled developing grain. Anal Biochem. 1983 Oct 15; 134(2):512-6. PMID: 6650835.
      View in: PubMed
    Matlashewski's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description